Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe.
about
Acceptability in microbicide and PrEP trials: current status and a reconceptualization.Microbicide clinical trial adherence: insights for introductionThe Sexual Acceptability of Contraception: Reviewing the Literature and Building a New Concept.Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study.Interest in multipurpose prevention of HIV and pregnancy: perspectives of women, men, health professionals and community stakeholders in two vaginal gel studies in southern Africa.The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention.
P2860
Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe.
@en
type
label
Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe.
@en
prefLabel
Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe.
@en
P2093
P2860
P1433
P1476
Preference between precoital and daily use of Duet® and BufferGel in Zimbabwe.
@en
P2093
Alix Lutnick
Ariane van der Straten
Cynthia Woodsong
Elizabeth Montgomery
Helen Cheng
Petina Musara
Sue Mavedzenge
P2860
P2888
P304
P356
10.1007/S10461-012-0256-4
P577
2012-10-01T00:00:00Z